These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 1922910

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Subcutaneous epoetin beta in renal anemia: an open multicenter dose titration study of patients on continuous peritoneal dialysis.
    Bárány P, Clyne N, Hylander B, Johansson AC, Simonsen O, Larsson R, Frisenette-Fich C, Svensson B, Helmers C.
    Perit Dial Int; 1995; 15(1):54-60. PubMed ID: 7734561
    [Abstract] [Full Text] [Related]

  • 3. Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessment.
    Hughes RT, Cotes PM, Pippard MJ, Stevens JM, Oliver DO, Winearls CG, Royston JP.
    Br J Haematol; 1990 Jun; 75(2):268-73. PubMed ID: 2372513
    [Abstract] [Full Text] [Related]

  • 4. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A, Reyes A, Valdés F, Otero A, López de Novales E, Pallardó L, Tabernero JM, Hernández Jaras J, Lladós F.
    Nefrologia; 2003 Jun; 23(2):114-24. PubMed ID: 12778875
    [Abstract] [Full Text] [Related]

  • 5. A comparison between once-weekly and twice- or thrice-weekly subcutaneous injection of epoetin alfa: results from a randomized controlled multicentre study.
    Lee YK, Kim SG, Seo JW, Oh JE, Yoon JW, Koo JR, Kim HJ, Noh JW.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3240-6. PubMed ID: 18469158
    [Abstract] [Full Text] [Related]

  • 6. [Changing the frequency of administration of darbepoetin alfa (from weekly to fortnightly) maintains the haemoglobin levels in patients undergoing peritoneal dialysis].
    Bajo MA, Pérez Fontán M, Remón C, Sánchez-Tomero JA, Lladós F, Selgas R.
    Nefrologia; 2009 Oct; 29(2):136-42. PubMed ID: 19396319
    [Abstract] [Full Text] [Related]

  • 7. Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients.
    Macdougall IC, Cavill I, Davies ME, Hutton RD, Coles GA, Williams JD.
    Contrib Nephrol; 1989 Oct; 76():219-26. PubMed ID: 2582780
    [No Abstract] [Full Text] [Related]

  • 8. Efficient monthly subcutaneous administration of darbepoetin in stable CAPD patients.
    Theodoridis M, Passadakis P, Kriki P, Panagoutsos S, Yannatos E, Kantartzi K, Sivridis D, Vargemezis V.
    Perit Dial Int; 2005 Oct; 25(6):564-9. PubMed ID: 16411523
    [Abstract] [Full Text] [Related]

  • 9. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
    Brunkhorst R, Bommer J, Braun J, Haag-Weber M, Gill C, Wagner J, Wagener T, German Aranesp Study Group.
    Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R, Epoetin Zeta Study Group.
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [Abstract] [Full Text] [Related]

  • 11. The efficacy and safety of once-weekly and once-fortnightly subcutaneous epoetin beta in peritoneal dialysis patients with chronic renal anaemia.
    Grzeszczak W, Sulowicz W, Rutkowski B, de Vecchi AF, Scanziani R, Durand PY, Bajo A, Vargemezis V, European Collaborative Group.
    Nephrol Dial Transplant; 2005 May; 20(5):936-44. PubMed ID: 15769814
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the therapeutic effects of epoetin zeta and epoetin alpha in the correction of renal anaemia.
    Krivoshiev S, Todorov VV, Manitius J, Czekalski S, Scigalla P, Koytchev R, Epoetin Zeta Study Group.
    Curr Med Res Opin; 2008 May; 24(5):1407-15. PubMed ID: 18394266
    [Abstract] [Full Text] [Related]

  • 13. Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study.
    Branger B, Vécina F, Zabadani B, Balducchi JP, Fourcade J.
    Nephrol Dial Transplant; 1995 May; 10 Suppl 6():36-9. PubMed ID: 8524492
    [Abstract] [Full Text] [Related]

  • 14. Subcutaneous treatment with recombinant human erythropoietin--the influence of injection frequency and skin-fold thickness.
    Brahm M.
    Scand J Urol Nephrol; 1999 Jun; 33(3):192-6. PubMed ID: 10452296
    [Abstract] [Full Text] [Related]

  • 15. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
    Cody J, Daly C, Campbell M, Donaldson C, Grant A, Khan I, Vale L, Wallace S, MacLeod A.
    Cochrane Database Syst Rev; 2002 Jun; (4):CD003895. PubMed ID: 12519614
    [Abstract] [Full Text] [Related]

  • 16. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Law CB, Ting SM, Li P, Lai KN.
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [Abstract] [Full Text] [Related]

  • 17. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W, Locatelli F, Ryckelynck JP, Balla J, Csiky B, Harris K, Ehrhard P, Beyer U, PROTOS Study Investigators.
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [Abstract] [Full Text] [Related]

  • 18. Darbepoetin alfa once monthly corrects anaemia in patients with chronic kidney disease not on dialysis.
    Roger SD, Kolmakova E, Fung M, Malecki R, Vinhas J, Dellanna F, Thomas M, Manamley N, Ferenczi S.
    Nephrology (Carlton); 2014 May; 19(5):266-74. PubMed ID: 24506498
    [Abstract] [Full Text] [Related]

  • 19. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK, Cy C, Chan MK, Yu L, Fang GX, Wei D.
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [Abstract] [Full Text] [Related]

  • 20. A trial of subcutaneous administration of darbepoetin alfa once every other week for the treatment of anemia in peritoneal dialysis patients.
    Mahajan S, Boulton H, Gokal R.
    J Nephrol; 2004 May; 17(5):687-92. PubMed ID: 15593036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.